Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product is the CADScor System, an exceptionally sensitive, non-invasive analytical device designed for the detection of coronary artery disease. Founded in 2009, Acarix AB (publ) maintains its headquarters in Malmö, Sweden.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'cheap' on P/E.
Target Price
The average target price of ACARIX.ST is 0.40 and suggests 86% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i